Ciraparantag

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCiraparantag
Drug Alias NameAripazine西帕兰他西帕他格Diarginine piperazineDAP +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsHemorrhagic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerosphere Inc
China Registration ClassN/A

Develop Information

Active CompaniesPerosphere IncNorgineAmag Pharmaceuticals Inc
Inactive CompaniesPerosphere Pharmaceuticals Inc
Active IndicationsHemorrhagic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia